ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) — FDA Approval ANDA205519 (SCIEGEN PHARMS)
ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) — FDA Approval ANDA205519 (SCIEGEN PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ATORVASTATIN CALCIUM; Active ingredients: ATORVASTATIN CALCIUM; Application number: ANDA205519.
| Brand name | ATORVASTATIN CALCIUM |
|---|---|
| Active ingredients | ATORVASTATIN CALCIUM |
| Application number | ANDA205519 |
| Sponsor | SCIEGEN PHARMS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 4 |
| First approval date | 20160519 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →